Page last updated: 2024-08-21

2-piperidone and Leukemia P388

2-piperidone has been researched along with Leukemia P388 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Allen, TM; Balzarini, J; De Clercq, E; Dimmock, JR; Jha, A; Manavathu, EK; Santos, CL; Selvakumar, P; Sharma, RK; Shrivastav, A; Stables, JP; Zello, GA1
Arora, VK; Dimmock, JR; Fang, WD; Hamon, NW; Jia, Z; Lee, JS; Quail, JW; Warrington, RC; Wonko, SL1

Other Studies

2 other study(ies) available for 2-piperidone and Leukemia P388

ArticleYear
3,5-bis(phenylmethylene)-1-(N-arylmaleamoyl)-4-piperidones: a novel group of cytotoxic agents.
    Journal of enzyme inhibition and medicinal chemistry, 2003, Volume: 18, Issue:4

    Topics: Animals; Anticonvulsants; Antifungal Agents; Antineoplastic Agents; Cell Line, Tumor; Leukemia L1210; Leukemia P388; Leukemia, T-Cell; Mice; Piperidones; T-Lymphocytes

2003
3,5-Bis-benzylidene-4-piperidones and related compounds with high activity towards P388 leukemia cells.
    Drug design and delivery, 1990, Volume: 6, Issue:3

    Topics: Animals; Antineoplastic Agents; Benzylidene Compounds; Cell Survival; DNA, Neoplasm; Glutathione; Leukemia P388; Liver; Maleates; Mice; Mice, Inbred Strains; Molecular Conformation; Nucleic Acid Denaturation; Piperidones; Structure-Activity Relationship; Tumor Cells, Cultured; X-Ray Diffraction

1990